United Kingdom AI in Pathology Market Insight
Published: 03 June 2026 | Report Format: Electronic (PDF)
The United Kingdom AI in Pathology Market is projected to grow at a CAGR of around 18.4%, driven by increasing adoption of digital pathology, AI-assisted diagnostics, growing demand for accurate disease detection, healthcare digitalization, and advancements in precision medicine technologies.
United Kingdom AI in Pathology Market Forecasts to 2035
- The United Kingdom AI in Pathology Market Size Was Estimated at USD 1.28 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 18.4% from 2025 to 2035
- The United Kingdom AI in Pathology Market Size is Expected to Reach around USD 6.98 Billion by 2035.
Notable Insights for the United Kingdom AI in Pathology Market
- Segmentation based on application, digital pathology and diagnostic imaging analysis dominated the United Kingdom AI in Pathology Market in 2025 with nearly 58% share, driven by increasing adoption of AI-powered image analysis, automated disease detection, enhanced diagnostic accuracy, and the growing demand for efficient pathology workflows.
- Segmentation based on end-use, hospitals and diagnostic laboratories accounted for approximately 62% share, a major portion of the United Kingdom AI in Pathology Market in 2025, supported by rising investments in healthcare digitalization, integration of AI-assisted diagnostic platforms, growing pathology testing volumes, and the need for faster and more precise clinical decision-making.
- The United Kingdom AI in Pathology Market is led by companies such as Microsoft, IBM, Philips, and Siemens Healthineers, collectively holding around 52% market share through advanced AI-driven pathology, diagnostic imaging, and healthcare analytics solutions.
- Growing adoption of AI-powered digital pathology, automated image analysis, predictive diagnostics, machine learning algorithms, and cloud-based pathology platforms is expected to improve diagnostic accuracy, reduce turnaround times, streamline laboratory workflows, and enhance overall pathology operational efficiency by nearly 30% across the United Kingdom.
Download the eBook (ToC)
Why Buy This Report
- Provides a comprehensive analysis of the impact of AI-powered diagnostic imaging, digital pathology platforms, predictive analytics, and automated workflow solutions on the growth of the United Kingdom AI in Pathology Market.
- Offers key insights into technological advancements such as machine learning algorithms, computer vision, deep learning-based image analysis, whole-slide imaging, and AI-assisted diagnostic systems used across pathology laboratories and healthcare institutions.
- Helps market participants evaluate competitive benchmarking, investment opportunities in digital pathology transformation, and expansion strategies of leading healthcare technology providers, pathology solution developers, and AI-driven diagnostics companies operating in the United Kingdom.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom AI in Pathology Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom AI in Pathology Market
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips N.V.
- PathAI
- Paige
- Ibex Medical Analytics
- Aiforia Technologies Plc
- Proscia Inc.
- Leica Biosystems
- Indica Labs
- Tempus AI
Recent Developments:
- In June 2025, PathAI received FDA clearance for its AISight Dx platform, strengthening AI-enabled digital pathology diagnostics through advanced image management, workflow automation, and primary diagnosis capabilities.
- In March 2025, Koninklijke Philips N.V. expanded its partnership with Ibex Medical Analytics and introduced an enhanced release of its IntelliSite Pathology Solution, improving AI-powered cancer diagnostics, workflow efficiency, and digital pathology adoption across healthcare institutions.
Market Segmentation:
United Kingdom AI in Pathology Market, By Technology
• Machine Learning & Deep Learning Algorithms
• Computer Vision & Image Analysis
• Natural Language Processing (NLP)
• Digital Pathology Platforms
• Predictive Analytics & Decision Support Systems
• Cloud-Based AI Pathology Solutions
United Kingdom AI in Pathology Market, By Application
• Cancer Detection & Diagnosis
• Histopathology Image Analysis
• Biomarker Discovery & Companion Diagnostics
• Disease Screening & Classification
• Laboratory Workflow Automation
• Precision Medicine & Personalized Treatment Planning
United Kingdom AI in Pathology Market, By End User
• Hospitals & Healthcare Providers
• Diagnostic Laboratories
• Academic & Research Institutions
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Pathology Service Providers
Expert Views:
The United Kingdom AI in Pathology Market is poised for substantial growth, driven by accelerating adoption of digital pathology, AI-assisted diagnostics, and precision medicine initiatives. Advancements in machine learning, computer vision, and automated workflow solutions are enhancing diagnostic accuracy and laboratory efficiency. Increasing healthcare digitalization and investments in intelligent diagnostic technologies are expected to strengthen market expansion and transform pathology services nationwide.
Author: Aditi and Govind By Spherical Insights and Consulting